Hillel Naon, MD

Associate Chief, Division of Gastroenterology, Hepatology and Nutrition
Director, Inflammatory Bowel Disease Program
Professor of Clinical Pediatrics, Keck School of Medicine of USC

Dr. Naon is a board certified pediatric gastroenterology and in Pediatrics in the Division of Gastroenterology, Hepatology and Nutrition at Children's Hospital of Los Angeles. Dr. Naon participates in national multicenter research studies and committees.

Clinical Interests

Dr. Naon specializes pediatric gastroenterology with a special interest in inflammatory bowel disease.


Medical School

Technion, Israel Institute of Technology


Rambam Medical Center


University of California Irvine Medical Center: Pediatric Residency


Children's Hospital Los Angeles: Pediatric Gastroenterology



Pediatrics and Pediatric Gastroenterology: American Board of Pediatrics


American Academy of Pediatrics; American Medical Association; North American Society for Pediatric Gastroenterology, Hepatology & Nutrition; American Gastroenterological Association; American College of Gastroenterology




Naon H, Thomas DW.  Secretory tumors of the pancreas.  In:  Wyllie R, Hyams JS, Eds: Pediatric gastrointestinal disease:  Pathophysiology, diagnosis, management.  Philadelphia, W.B. Saunders Elsevier Inc,  Fourth edition 2011.

Peered Review Articles

Bhardwaj V, Harb R and Naon H.  Eosinophilic Esophagitis: A Clinicopathological Review. Special Issue on Pediatric Gastroenterology Disorders. Published online, February. Annals of Pediatrics and Child health. ISSN: 2373-9312. 2015: 3 (2)1040

Pietzak M and Naon H. Celiac Disease and Non-Celiac Gluten Sensitivity.  Special Issue on Pediatric Gastroenterology Disorders. Published online, February, Annals of Pediatrics and Child health.  2015, ISSN: 2373-9312. 2015: 3(2)1041

Kerkar N and Naon H. Autoimmune Liver Disease in Children.  and Child health. Special Issue on Pediatric Gastroenterology Disorders. Published online, February, Annals of Pediatrics and Child health. ISSN: 2373-9312.2015;  2015:3(2)1045

Danialifar T, S. Zhou, Naon H: Intestinal pneumatosis associated with infliximab therapy in a patient with ulcerative colitis. Practical Gastroenterology, April 2016


Research Summary

Ongoing research studies, include:

A Non-Interventional Long-term Post-Marketing Registry of patients treated with Certolizumab  Pegol (Cimzia®) for Crohn’ Disease.  A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of Humira® (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease (CD).  Long Term Registry of Multicenter, Prospective study of Pediatric Patients with inflammatory Bowel Disease treated with Remicade. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects with Moderate to Severe Ulcerative Colitis.  A Phase 4, Multicenter, Open-label Study of Serum Infliximab Concentrations and Efficacy and Safety of Dose Escalation in Pediatric Patients with Inflammatory Bowel Disease

Research Studies

To improve patient care and achieve the best health outcomes possible for children with IBD
evaluate long-term safety of Humira in pediatric patients (between the ages of 6 and 17 years inclusive at the time of enrollment) with moderately to severely active CD who are prescribed and treated...